Variant report

Variant	nsv5671
Chromosome Location	chr7:26118646-26155496
allele	n/a
Outlinks	Ensembl UCSC

Chromatin state
Related regulatory elements
Target genes
Other information

TF binding
region (count:0)
CpG islands
(count:0)
Chromatin interactive
region (count:86)
LncRNA
region (count:2)
Mature miRNA
region (count: 0)
miRNA target
sites (count:0)

No data

(count:86 , 50 per page) page: 1 2

No.	Distal block	Cell Line	Cell type
1	chr7:26126753..26129598-chr7:26130419..26132828,3	K562	blood:
2	chr7:26116496..26120025-chr7:26124167..26127570,3	MCF-7	breast:
3	chr7:26120079..26121816-chr7:26128176..26130468,2	K562	blood:
4	chr7:26152221..26157308-chr7:26225005..26229751,7	K562	blood:
5	chr7:26124079..26126684-chr7:26237086..26240273,4	MCF-7	breast:
6	chr7:26123870..26125696-chr7:26226783..26229178,2	MCF-7	breast:
7	chr7:26130269..26131203-chr7:26324356..26325072,3	K562	blood:
8	chr7:26131124..26132975-chr7:26134853..26136801,2	K562	blood:
9	chr7:26112064..26114800-chr7:26118641..26120981,2	K562	blood:
10	chr7:26134161..26136379-chr7:26242320..26244096,2	K562	blood:
11	chr7:26126033..26128739-chr7:26129365..26131958,3	MCF-7	breast:
12	chr7:26126305..26129045-chr7:26235519..26238243,2	MCF-7	breast:
13	chr22:49929400..49929920-chr7:26140865..26141585,2	NB4	blood:
14	chr7:26136960..26140512-chr7:26226454..26229545,3	K562	blood:
15	chr7:26118648..26123140-chr7:26237417..26242169,5	K562	blood:
16	chr7:26130771..26133250-chr7:26224106..26227853,3	MCF-7	breast:
17	chr7:26121372..26122991-chr7:26241151..26242996,2	MCF-7	breast:
18	chr7:26149919..26152511-chr7:26155274..26157717,3	K562	blood:
19	chr7:26119926..26122266-chr7:26227984..26229588,2	MCF-7	breast:
20	chr7:26111175..26113730-chr7:26115998..26118801,2	MCF-7	breast:
21	chr7:26120211..26123074-chr7:26126513..26128042,2	MCF-7	breast:
22	chr7:26127005..26130353-chr7:26231092..26235350,4	MCF-7	breast:
23	chr7:26121331..26123679-chr7:26220972..26223224,2	MCF-7	breast:
24	chr7:26127176..26132084-chr7:26132908..26137367,5	K562	blood:
25	chr7:26129567..26132077-chr7:26220760..26223665,4	MCF-7	breast:
26	chr7:26122995..26125751-chr7:26126126..26128926,3	K562	blood:
27	chr7:26134385..26136107-chr7:26239301..26241163,2	K562	blood:
28	chr7:26122863..26125751-chr7:26125996..26128926,3	K562	blood:
29	chr7:26138953..26140614-chr7:26142057..26143746,2	K562	blood:
30	chr7:26126033..26128739-chr7:26129365..26131958,3	MCF-7	breast:
31	chr7:26117990..26136794-chr7:26219781..26234338,53	K562	blood:
32	chr7:26138953..26140614-chr7:26142057..26143746,2	K562	blood:
33	chr7:26126882..26129598-chr7:26130419..26133130,2	K562	blood:
34	chr7:26127085..26136794-chr7:26224123..26230309,16	K562	blood:
35	chr7:26123460..26125747-chr7:26131738..26134099,3	K562	blood:
36	chr7:26146073..26148941-chr7:26224609..26227830,4	K562	blood:
37	chr7:26126753..26129598-chr7:26130419..26132828,3	K562	blood:
38	chr7:26117230..26119075-chr7:26243956..26245762,2	K562	blood:
39	chr7:26131775..26133485-chr7:26328887..26331564,2	K562	blood:
40	chr7:26120586..26123734-chr7:26238945..26240638,3	MCF-7	breast:
41	chr7:26120022..26122895-chr7:26235605..26238728,3	MCF-7	breast:
42	chr7:26133229..26135657-chr7:26144514..26146950,2	MCF-7	breast:
43	chr7:26127176..26132084-chr7:26132908..26137367,5	K562	blood:
44	chr7:26125058..26127925-chr7:26238815..26242707,3	MCF-7	breast:
45	chr7:26123460..26125747-chr7:26131738..26134099,3	K562	blood:
46	chr7:26120211..26123074-chr7:26126513..26128042,2	MCF-7	breast:
47	chr7:26122904..26124526-chr7:26129160..26131846,3	MCF-7	breast:
48	chr7:26152455..26156873-chr7:26226826..26229761,5	K562	blood:
49	chr7:26129819..26132653-chr7:26238402..26240487,3	K562	blood:
50	chr7:26130355..26130891-chr7:26404343..26405006,2	MCF-7	breast:

(count:2 , 50 per page) page: 1

No.	lncRNA name	Chromosome Location	lncRNA alias
1	lnc-HNRNPA2B1-9	chr7:26134420-26134615	l_3383_chr7:26064190-26136923_testes
2	lnc-HNRNPA2B1-9	chr7:26136736-26136923	l_3383_chr7:26064190-26136923_testes

No data

Variant related genes	Relation type
ENSG00000050344	chromatin interactions
ENSG00000122565	chromatin interactions
ENSG00000086300	chromatin interactions
ENSG00000122566	chromatin interactions

Extended variants
information (count: 1306 )
Associated
traits (count: 77 )

Variant overlapped rSNPs/rCNVs (count:1306 , 50 per page) page: 1 2 3 4 5 6 7 ... 27

No.	Variant name	Chromosome position	Chromatin state	Related regulatory elements	Target genes	Extended variants	Associated traits
1	rs532531862	chr7:26118655-26118656	Active TSS Enhancers Bivalent Enhancer Weak transcription Flanking Active TSS Flanking Bivalent TSS/Enh Bivalent/Poised TSS	Chromatin interactive region	3 gene(s)	Overlapped CNVs	n/a
2	rs148816166	chr7:26118668-26118669	Active TSS Enhancers Bivalent Enhancer Weak transcription Flanking Active TSS Flanking Bivalent TSS/Enh Bivalent/Poised TSS	Chromatin interactive region	3 gene(s)	Overlapped CNVs	n/a
3	rs566121286	chr7:26118697-26118698	Active TSS Enhancers Bivalent Enhancer Weak transcription Flanking Active TSS Flanking Bivalent TSS/Enh Bivalent/Poised TSS	Chromatin interactive region	3 gene(s)	Overlapped CNVs	n/a
4	rs143498781	chr7:26118703-26118704	Active TSS Enhancers Bivalent Enhancer Weak transcription Flanking Active TSS Flanking Bivalent TSS/Enh Bivalent/Poised TSS	Chromatin interactive region	3 gene(s)	Overlapped CNVs	n/a
5	rs548013850	chr7:26118714-26118715	Active TSS Enhancers Bivalent Enhancer Weak transcription Flanking Active TSS Flanking Bivalent TSS/Enh Bivalent/Poised TSS	Chromatin interactive region	3 gene(s)	Overlapped CNVs	n/a
6	rs184222336	chr7:26118740-26118741	Active TSS Enhancers Bivalent Enhancer Weak transcription Flanking Active TSS Flanking Bivalent TSS/Enh Bivalent/Poised TSS	Chromatin interactive region	3 gene(s)	Overlapped CNVs	n/a
7	rs188626394	chr7:26118741-26118742	Active TSS Enhancers Bivalent Enhancer Weak transcription Flanking Active TSS Flanking Bivalent TSS/Enh Bivalent/Poised TSS	Chromatin interactive region	3 gene(s)	Overlapped CNVs	n/a
8	rs533879655	chr7:26118757-26118758	Active TSS Enhancers Bivalent Enhancer Weak transcription Flanking Active TSS Flanking Bivalent TSS/Enh Bivalent/Poised TSS	Chromatin interactive region	3 gene(s)	Overlapped CNVs	n/a
9	rs556827494	chr7:26118772-26118773	Active TSS Enhancers Bivalent Enhancer Weak transcription Flanking Active TSS Flanking Bivalent TSS/Enh Bivalent/Poised TSS	Chromatin interactive region	3 gene(s)	Overlapped CNVs	n/a
10	rs373351480	chr7:26118778-26118779	Active TSS Enhancers Bivalent Enhancer Weak transcription Flanking Active TSS Flanking Bivalent TSS/Enh Bivalent/Poised TSS	Chromatin interactive region	3 gene(s)	Overlapped CNVs	n/a
11	rs550702226	chr7:26118798-26118799	Active TSS Enhancers Bivalent Enhancer Weak transcription Flanking Active TSS Flanking Bivalent TSS/Enh Bivalent/Poised TSS	Chromatin interactive region	3 gene(s)	Overlapped CNVs	n/a
12	rs570361865	chr7:26118823-26118824	Active TSS Enhancers Bivalent Enhancer Flanking Bivalent TSS/Enh Weak transcription Flanking Active TSS Bivalent/Poised TSS	Chromatin interactive region	3 gene(s)	Overlapped CNVs	n/a
13	rs539371757	chr7:26118828-26118829	Active TSS Enhancers Bivalent Enhancer Flanking Bivalent TSS/Enh Weak transcription Flanking Active TSS Bivalent/Poised TSS	Chromatin interactive region	3 gene(s)	Overlapped CNVs	n/a
14	rs35639689	chr7:26118949-26118950	Active TSS Enhancers Bivalent Enhancer Flanking Bivalent TSS/Enh Weak transcription Flanking Active TSS Bivalent/Poised TSS	Chromatin interactive region	3 gene(s)	Overlapped CNVs	n/a
15	rs552814881	chr7:26119054-26119055	Active TSS Enhancers Bivalent Enhancer Weak transcription Bivalent/Poised TSS Flanking Bivalent TSS/Enh	Chromatin interactive region	3 gene(s)	Overlapped CNVs	n/a
16	rs6963094	chr7:26119078-26119079	Active TSS Enhancers Bivalent Enhancer Weak transcription Bivalent/Poised TSS Flanking Bivalent TSS/Enh	Chromatin interactive region	3 gene(s)	LD-proxies of rSNP Overlapped rCNV	n/a
17	rs535528428	chr7:26119139-26119140	Active TSS Enhancers Bivalent Enhancer Weak transcription Bivalent/Poised TSS Flanking Bivalent TSS/Enh	Chromatin interactive region	3 gene(s)	Overlapped CNVs	n/a
18	rs368831056	chr7:26119173-26119174	Active TSS Enhancers Bivalent Enhancer Weak transcription Bivalent/Poised TSS Flanking Bivalent TSS/Enh	Chromatin interactive region	3 gene(s)	Overlapped CNVs	n/a
19	rs192753106	chr7:26119184-26119185	Active TSS Enhancers Bivalent Enhancer Weak transcription Bivalent/Poised TSS Flanking Bivalent TSS/Enh	Chromatin interactive region	3 gene(s)	Overlapped CNVs	n/a
20	rs544170115	chr7:26119293-26119294	Weak transcription Enhancers Bivalent Enhancer	Chromatin interactive region	3 gene(s)	Overlapped CNVs	n/a
21	rs563969099	chr7:26119301-26119302	Weak transcription Enhancers Bivalent Enhancer	Chromatin interactive region	3 gene(s)	Overlapped CNVs	n/a
22	rs577174041	chr7:26119317-26119318	Weak transcription Enhancers Bivalent Enhancer	Chromatin interactive region	3 gene(s)	Overlapped CNVs	n/a
23	rs546153209	chr7:26119342-26119343	Weak transcription Enhancers Bivalent Enhancer	Chromatin interactive region	3 gene(s)	Overlapped CNVs	n/a
24	rs573060294	chr7:26119385-26119386	Weak transcription Enhancers Bivalent Enhancer	Chromatin interactive region	3 gene(s)	Overlapped CNVs	n/a
25	rs73683227	chr7:26119448-26119449	Weak transcription Enhancers Bivalent Enhancer	Chromatin interactive region	3 gene(s)	LD-proxies of rSNP Overlapped rCNV	n/a
26	rs77730855	chr7:26119486-26119487	Weak transcription Enhancers Bivalent Enhancer	Chromatin interactive region	3 gene(s)	Overlapped CNVs	n/a
27	rs182084103	chr7:26119500-26119501	Weak transcription Enhancers Bivalent Enhancer	Chromatin interactive region	3 gene(s)	Overlapped CNVs	n/a
28	rs553738043	chr7:26119567-26119568	Weak transcription Enhancers Bivalent Enhancer	Chromatin interactive region	3 gene(s)	Overlapped CNVs	n/a
29	rs376885307	chr7:26119568-26119569	Weak transcription Enhancers Bivalent Enhancer	Chromatin interactive region	3 gene(s)	Overlapped CNVs	n/a
30	rs572679965	chr7:26119595-26119596	Weak transcription Enhancers Bivalent Enhancer	Chromatin interactive region	3 gene(s)	Overlapped CNVs	n/a
31	rs186598681	chr7:26119626-26119627	Weak transcription Bivalent Enhancer	Chromatin interactive region	3 gene(s)	Overlapped CNVs	n/a
32	rs114213067	chr7:26119639-26119640	Weak transcription Bivalent Enhancer	Chromatin interactive region	3 gene(s)	Overlapped CNVs	n/a
33	rs191791515	chr7:26119642-26119643	Weak transcription Bivalent Enhancer	Chromatin interactive region	3 gene(s)	Overlapped CNVs	n/a
34	rs4722566	chr7:26119695-26119696	Weak transcription Bivalent Enhancer	Chromatin interactive region	3 gene(s)	LD-proxies of rSNP Overlapped rCNV	n/a
35	rs542889742	chr7:26119706-26119707	Weak transcription Bivalent Enhancer	Chromatin interactive region	3 gene(s)	Overlapped CNVs	n/a
36	rs71521747	chr7:26119761-26119762	Weak transcription Bivalent Enhancer	Chromatin interactive region	3 gene(s)	Overlapped CNVs	n/a
37	rs11434047	chr7:26119771-26119772	Weak transcription Bivalent Enhancer	Chromatin interactive region	3 gene(s)	Overlapped CNVs	n/a
38	rs566324700	chr7:26119811-26119812	Weak transcription Bivalent Enhancer	Chromatin interactive region	3 gene(s)	Overlapped CNVs	n/a
39	rs544613280	chr7:26119820-26119821	Weak transcription Bivalent Enhancer	Chromatin interactive region	3 gene(s)	Overlapped CNVs	n/a
40	rs147892363	chr7:26119821-26119822	Weak transcription Bivalent Enhancer	Chromatin interactive region	3 gene(s)	Overlapped CNVs	n/a
41	rs560060594	chr7:26119824-26119825	Weak transcription Bivalent Enhancer	Chromatin interactive region	3 gene(s)	Overlapped CNVs	n/a
42	rs562165686	chr7:26119846-26119847	Weak transcription Bivalent Enhancer	Chromatin interactive region	3 gene(s)	Overlapped CNVs	n/a
43	rs570845107	chr7:26119851-26119852	Weak transcription Bivalent Enhancer	Chromatin interactive region	3 gene(s)	Overlapped CNVs	n/a
44	rs139438483	chr7:26119857-26119858	Weak transcription Bivalent Enhancer	Chromatin interactive region	3 gene(s)	Overlapped CNVs	n/a
45	rs150947195	chr7:26119859-26119860	Weak transcription Bivalent Enhancer	Chromatin interactive region	3 gene(s)	Overlapped CNVs	n/a
46	rs575096887	chr7:26119925-26119926	Weak transcription Bivalent Enhancer	Chromatin interactive region	3 gene(s)	Overlapped CNVs	n/a
47	rs377172514	chr7:26119952-26119953	Weak transcription Bivalent Enhancer	Chromatin interactive region	3 gene(s)	Overlapped CNVs	n/a
48	rs537598880	chr7:26120023-26120024	Weak transcription Enhancers	Chromatin interactive region	3 gene(s)	Overlapped CNVs	n/a
49	rs141065951	chr7:26120032-26120033	Weak transcription Enhancers	Chromatin interactive region	3 gene(s)	Overlapped CNVs	n/a
50	rs183973987	chr7:26120059-26120060	Weak transcription Enhancers	Chromatin interactive region	3 gene(s)	Overlapped CNVs	n/a

Variant related diseases (count:77)

Disease	PMID	Source
Urothelial carcinoma	18382360	CNVD
Medulloblastoma	21979893	CNVD
Lynch syndrome	18415027	CNVD
Biliary cancer	19435499	CNVD
Cancer	16751803	CNVD
Invasive pancreatic ductal carcinoma	16982739	CNVD
Wilms tumour	21544195	CNVD
Glioblastoma multiforme	17387387	CNVD
Astrocytoma	17387387	CNVD
Esophageal squamous carcinoma	21637470	CNVD
Neuroblastoma	18923191	CNVD
Glioma	21971842	CNVD
Glioblastoma multiforme	21080181	CNVD
Liposarcoma	21253554	CNVD
Oligodendroglial tumors	17285580	CNVD
Oral cancer	21386901	CNVD
colon cancer	17210682	CNVD
Lung adenocarcinoma	21810691	CNVD
Endometrial cancer	22040021	CNVD
Breast cancer	21264507	CNVD
Colorectal cancer	19359472	CNVD
Hypothalamic hamartomas	18252217	CNVD
Human rectal carcinomas	16397240	CNVD
Peripheral t-cell lymphoma	19118030	CNVD
Medulloblastoma	18056178	CNVD
Basal cell lymphoma	17170743	CNVD
Ewing''s sarcoma	21437220	CNVD
Thyroid cancer	19087340	CNVD
Seminomas	18059402	CNVD
Testicular cancer	18059402	CNVD
Chronic lymphocytic leukemia	21546498	CNVD
Autism	19415332	CNVD
Pleomorphic xanthoastrocytoma	20730472	CNVD
T-cell lymphomas	19863542	CNVD
Malaria	21533027	CNVD
Melanoma	18172304	CNVD
Renal cell carcinoma	19461508	CNVD
head and neck squamous cell carcinoma	19289630	CNVD
Stenocardia	21860640	CNVD
Vasospasm	21860640	CNVD
T-cell prolymphocytic leukemia	19278963	CNVD
Acute lymphoblastic leukemia	20435627	CNVD
Ewing''s sarcoma	17952124	CNVD
Hodgkin''s lymphoma	17606441	CNVD
Breast cancer	21364760	CNVD
Thoracic aortic aneurysm	21092924	CNVD
Lung cancer	18438408	CNVD
small cell lung cancer	20016488	CNVD
Leukemia	23979775	CNVD
lymphocytic leukemia	21291569	CNVD
Acute lymphoblastic leukemia	22237106	CNVD
Autism	22495311	CNVD
Endometrioid adenocarcinoma	16974079	CNVD
Gastrointestinal stromal cancer	20877625	CNVD
Cancer	21637783	CNVD
Squamous cell cancer	20885788	CNVD
Breast cancer	16397240	CNVD
Non-small cell lung cancer	21829676	CNVD
Glioblastoma multiforme	17002787	CNVD
Malignant peripheral nerve sheath tumor	18522746	CNVD
Glioblastoma multiforme	18628472	CNVD
Non-syndromic sensorineural hearing loss	22570644	CNVD
Cancer	21183584	CNVD
abnormal development	18461090	CNVD
High-grade prostatic intraepithelial neoplasia	16573809	CNVD
Breast cancer	21785460	CNVD
Follicular lymphoma	20505157	CNVD
Williams-beuren syndrome	22470819	CNVD
Pleomorphic liposarcoma	18784837	CNVD
Colorectal cancer	16774939	CNVD
Myelofibrosis	22110671	CNVD
Colorectal cancer	21645411	CNVD
Lung adenocarcinoma	17086460	CNVD
Colorectal cancer	19455253	CNVD
Lung cancer	17086460	CNVD
Breast cancer	18852474	CNVD
Pancreatic cancer	17952125	CNVD

Chromatin state (count:751 , 50 per page) page: 1 2 3 4 5 6 7 ... 16

No.	Chromosome Location	Chromatin state	Cell line	Tissue
1	chr7:26115600-26118800	Weak transcription	HepG2	liver
2	chr7:26118000-26118800	Active TSS	Rectal Smooth Muscle	rectum
3	chr7:26118000-26118800	Bivalent Enhancer	Dnd41	blood
4	chr7:26118000-26119000	Bivalent Enhancer	Fetal Stomach	stomach
5	chr7:26118000-26119200	Enhancers	Fetal Intestine Large	intestine
6	chr7:26118000-26119400	Enhancers	Fetal Thymus	thymus
7	chr7:26118200-26119000	Enhancers	Primary hematopoietic stem cells G-CSF-mobilized Female	--
8	chr7:26118200-26119200	Bivalent Enhancer	Primary T helper cells fromperipheralblood	blood
9	chr7:26118200-26119600	Bivalent Enhancer	Colon Smooth Muscle	Colon
10	chr7:26118400-26118800	Bivalent Enhancer	H9 Derived Neuronal Progenitor Cultured Cells	ES cell derived
11	chr7:26118400-26118800	Enhancers	HUES48 Cell Line	embryonic stem cell
12	chr7:26118400-26118800	Enhancers	HUES6 Cell Line	embryonic stem cell
13	chr7:26118400-26118800	Enhancers	HUES64 Cell Line	embryonic stem cell
14	chr7:26118400-26118800	Enhancers	iPS-18 Cell Line	embryonic stem cell
15	chr7:26118400-26118800	Bivalent Enhancer	Primary B cells from cord blood	blood
16	chr7:26118400-26118800	Bivalent Enhancer	Primary T helper memory cells from peripheral blood 2	blood
17	chr7:26118400-26118800	Enhancers	Primary T helper naive cells fromperipheralblood	blood
18	chr7:26118400-26118800	Bivalent Enhancer	Primary T helper 17 cells PMA-I stimulated	--
19	chr7:26118400-26118800	Bivalent Enhancer	Primary T killer memory cells from peripheral blood	blood
20	chr7:26118400-26118800	Flanking Active TSS	Ganglion Eminence derived primary cultured neurospheres	brain
21	chr7:26118400-26118800	Bivalent Enhancer	Brain Cingulate Gyrus	brain
22	chr7:26118400-26118800	Bivalent Enhancer	Brain Hippocampus Middle	brain
23	chr7:26118400-26118800	Bivalent Enhancer	Brain Inferior Temporal Lobe	brain
24	chr7:26118400-26118800	Enhancers	Brain Substantia Nigra	brain
25	chr7:26118400-26118800	Enhancers	Fetal Adrenal Gland	Adrenal Gland
26	chr7:26118400-26118800	Weak transcription	Fetal Intestine Small	intestine
27	chr7:26118400-26118800	Enhancers	Rectal Mucosa Donor 31	rectum
28	chr7:26118400-26119000	Active TSS	iPS-20b Cell Line	embryonic stem cell
29	chr7:26118400-26119000	Enhancers	Breast Myoepithelial Primary Cells	Breast
30	chr7:26118400-26119000	Enhancers	Breast variant Human Mammary Epithelial Cells (vHMEC)	Breast
31	chr7:26118400-26119000	Bivalent Enhancer	Primary monocytes fromperipheralblood	blood
32	chr7:26118400-26119000	Enhancers	Primary hematopoietic stem cells	blood
33	chr7:26118400-26119000	Enhancers	Primary hematopoietic stem cells short term culture	blood
34	chr7:26118400-26119000	Bivalent Enhancer	Primary T helper memory cells from peripheral blood 1	blood
35	chr7:26118400-26119000	Bivalent Enhancer	Primary T helper cells PMA-I stimulated	--
36	chr7:26118400-26119000	Flanking Active TSS	Primary hematopoietic stem cells G-CSF-mobilized Male	--
37	chr7:26118400-26119000	Bivalent Enhancer	Foreskin Keratinocyte Primary Cells skin03	Skin
38	chr7:26118400-26119000	Active TSS	Brain Germinal Matrix	brain
39	chr7:26118400-26119000	Bivalent Enhancer	Fetal Lung	lung
40	chr7:26118400-26119200	Active TSS	ES-I3 Cell Line	embryonic stem cell
41	chr7:26118400-26119200	Enhancers	H1 Cell Line	embryonic stem cell
42	chr7:26118400-26119200	Enhancers	hESC Derived CD184+ Endoderm Cultured Cells	ES cell derived
43	chr7:26118400-26119200	Enhancers	iPS-15b Cell Line	embryonic stem cell
44	chr7:26118400-26119200	Bivalent Enhancer	Primary B cells from peripheral blood	blood
45	chr7:26118400-26119200	Enhancers	Primary T cells from cord blood	blood
46	chr7:26118400-26119200	Bivalent Enhancer	Primary T helper naive cells from peripheral blood	blood
47	chr7:26118400-26119200	Active TSS	Fetal Brain Female	brain
48	chr7:26118400-26119400	Enhancers	ES-UCSF4 Cell Line	embryonic stem cell
49	chr7:26118400-26119600	Enhancers	Fetal Kidney	kidney
50	chr7:26118400-26121200	Weak transcription	hESC Derived CD56+ Ectoderm Cultured Cells	ES cell derived

The 2.0 version of rSNPBase

Variant report

Quick Search:

what's new

Quick links